Cyrano Therapeutics
cyranotherapeutics.com
Actively hiring
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$13.1M
2 rounds on record
Latest round
$9M
Series B · Jan 2024 · 2 yr ago
Team
11-50
employees, estimated range
Backers
2
Florida Opportunity Fund, Lumira Ventures
The money's age
Long since its last round
32 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 4, 2020
Raised a round Venture round $4.1M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Jan 2024 | $9M | — | streetinsider.com |
| Venture round | Nov 2020 | $4.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Cyrano Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Richard GeoffrionExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Florida Opportunity Fund 
Lumira Ventures Similar startupsby what they do, their industry and backers
通話内容の重要箇所をpick upしsalesforce セールスフォース Senses センシーズなどSFAへ自動入力・共有してくれるAI IP電話 pickuponピクポンのページです…
Embold helps development teams prevent technical debt with automated static code analysis. Find vulnerabilities, anti-patterns, and code…
Sensmore engineering, not only do we sense more data, we make more sense.
We develop highly selective polymer-based sensors to detect gas VOCs in the ppb range, in real-time. We combine custom hardware with…
Koshex helps you make sense of money - practical, plain-language guidance on budgeting, saving and investing.
Biological Intelligence Over millions of years, our olfactory system has evolved into the most powerful chemical detector on the planet. By…
News
Intranasal Delivery for Post-Viral Smell Loss with Cyrano Therapeutics' Rick Geoffrion
Your browser can't play this video. Watch it here. Restoring Smell at the Source: Rick Geoffrion on Sit and Deliver More than 50 million people in the U.S. and Europe live with smell loss after a viral infection. There are still no scientifically validate
Read more
Report
CYR-064 Phase 2 FLAVOR Trial Results to be Featured at the 72nd Annual Meeting of the American Rhinologic Society
Oral presentation to highlight Phase 2 data evaluating CYR-064 for persistent post-viral loss of smell DELRAY BEACH, Fla., July 29, 2026 /PRNewswire/ - Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company developing novel treatments f
Read more
Report
Cyrano Therapeutics Announces Positive Topline Results from Phase 2 FLAVOR Trial of CYR-064, a Proprietary and Potential First-to-Market Regenerative Therapy for Persistent Smell Loss
Trial met its primary safety and key prespecified secondary efficacy endpoints, supporting advancement into Phase 3 development in 2H 2026 DELRAY BEACH, Fla., February 17, 2026- Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company dev
Read more
Report
Cyrano Therapeutics Announces Positive Topline Results from Phase 2 FLAVOR Trial of CYR-064, a Proprietary and Potential First-to-Market Regenerative Therapy for Persistent Smell Loss
Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company developing novel treatments for smell and taste disorders, today announced positive topline results from its Phase 2 FLAVOR trial of CYR-064, an innovative, intranasal soft-mist spr
Read more
Report
Pro access
Upgrade to see all 16 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Richard Geoffrion
Executive Officer, Director
Gerry Brunk
Director
Takahide Koda
Director
Robert Henkin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Washington
United States
HQ
Delray Beach
United States
Regional office
Address
190 Congress Park Dr. - Ste 210, Delray Beach, FL 33445